ArticlePloS one2015

Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities.

Masaki Kurogochi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.